Effect of Conditioning Horses Once,Twice, or Thrice a Week with High-Intensity Intermittent Exercise on v4

Intensive short intervals of exercise are used to condition horses for racing. In this study, the effect of exercising horses one, two, or three times a week during 6 weeks using two intervals with near-maximal speed over 100 m on v₄ (speed at which, under defined conditions, the blood lactate concentration reaches 4 mmol/L) and muscle thickness (MT) of supraspinatus and extensor carpi radialis was examined. Thoroughbreds (4-5 years of age) were exercised twice at near-maximal speed over 100 m, separated by a 10-minute period at walk, on dirt track during conditioning periods (CP) of 6-week duration. This exercise was undertaken once (six horses), twice (six horses), or thrice (five horses) a week during a CP. Before, every 2 weeks during, and 2 weeks after the CP, horses were subjected to a standardized exercise test to determine their v₄. Before and after CP, the MT of the extensor carpi radialis and the supraspinatus was examined by ultrasonography. There was no differential effect of the number of weekly exercises on v₄. Pooling the data of all horses, a decrease of v₄ was found. The decrease became evident after the sixth week of conditioning. MT did not change. The results indicate that the examined exercise protocols could negatively impact racing performance of horses.     

Effect of Recovery Periods during Conditioning of Horses on Fitness Parameters

The effect of recovery from training has not been studied in horses. Therefore, the effect of recovery was examined with exercise of known effect within a conditioning period (CP). A standardized exercise test was performed at the beginning of CP to determine v₄, v₁₀, and v₁₈₀ (horse’s speed, which produced a blood lactate concentration of 4 and 10 mmol/L and a heart rate of 180 beats/min). Six horses were conditioned for three periods of 2 weeks, 5 times per fortnight at their individual v₁₀ for two bouts of 5 minutes on a treadmill. Every 2 weeks of conditioning was followed by 1 week with reduced workload. Standardized exercise test was repeated after each 2 weeks of conditioning and 2 weeks after finishing CP. Exercise speed was individually adapted to the new v₁₀ for every 2 weeks of conditioning. In addition, peak oxygen consumption before, after 3 weeks of conditioning, and at the end of the CP was measured. The mean v₄ increased steadily during CP. v₁₈₀ did not change, whereas peak oxygen consumption increased between the beginning and after 3 weeks of conditioning and leveled off thereafter. In conclusion, reducing the workload for 1 week after 2 weeks of conditioning 5 times per fortnight at v₁₀ for two bouts of 5 minutes allowed for a continuous increase of v₄, but the extent of the increase was smaller than in another study with a similar conditioning program but for the recovery week. The effect of recovery from training needs further studies.     

Validation of the Lactate Plus Lactate Meter in the Horse and Its Use in a Conditioning Program

The equine industry has a need for a convenient, rapid, and reliable method of measuring blood lactate concentrations ([LA]). We hypothesized that the handheld Lactate Plus lactate meter (LPlus), developed and tested for use in humans, would provide dependable results when used in horses undergoing an exercise conditioning program and that horse's fitness would improve following individualized conditioning based on each horse's velocity at which [LA] = 4 mmol/L (V_LA4) was reached. Five adult horses underwent a 4-week training program that consisted of 3 exercise bouts/wk. Horses were subjected to an incremental step standardized exercise test (SET) before starting (SET-1) and after the completion of the program (SET-2). Blood samples were collected before each increase in speed until [LA] reached ≥4 mmol/L, and then the SET was terminated. The [LA] sample range in our study was 0–8 mmol/L. Blood was analyzed at the time of collection using a calibrated LPlus, and plasma was collected for [LA] determination using the lactate dehydrogenase–based enzymatic colorimetric method. Although the LPlus tended to significantly underestimate [LA] by 0.39 mmol/L (P < .001), the LPlus proved to be a dependable device for use in horses based on good correlation with the biochemical analysis (r = 0.978) and Bland–Altman limits of agreement and 95% confidence intervals. All horses showed an increase in V_LA4 from SET-1 to SET-2, consistent with improved fitness following our 3 exercise bout/wk training protocol. The LPlus can reliably be used in horses to determine [LA] ranging from 0–8 mmol/L. When determining serial [LA], analytical techniques should not be used interchangeably.     

Dietary supplementation of a Saccharomyces cerevisiae fermentation product attenuates exercise-induced stress markers in young horses

Mitigation of exercise-induced stress is of key interest in determining ways to optimize performance horse health. To test the hypothesis that dietary supplementation of a Saccharomyces cerevisiae fermentation product would decrease markers of exercise-induced stress and inflammation in young horses, Quarter Horse yearlings (mean ± SD; 9 ± 1 mo) were randomly assigned to receive either no supplementation (CON; n = 8) or 21 g/d S. cerevisiae fermentation product (10.5 g/feeding twice daily; SCFP; n = 10) top-dressed on a basal diet of custom-formulated grain as well as ad libitum Coastal bermudagrass hay. After 8 wk of dietary treatments, horses underwent a 2-h submaximal exercise test (SET) on a free-stall mechanical exerciser. Serum was collected before dietary treatment supplementation (week 0), at week 8 pre-SET, and 0, 1, and 6 h post-SET and analyzed for concentrations of cortisol and serum amyloid A (SAA) by commercial enzyme-linked immunosorbent assay (ELISA) and for cytokine concentrations by commercial bead-based ELISA. Data were analyzed using linear models with repeated measures in SAS v9.4. From week 0 to 8 (pre-SET), serum cortisol decreased (P = 0.01) and SAA did not change, but neither were affected by diet. Serum concentrations of all cytokines decreased from week 0 to 8 (P ≤ 0.008), but granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor, and interleukin-8 (IL-8) decreased to a greater extent in CON than in SCFP horses (P ≤0.003). In response to the week 8 SET, serum cortisol increased in all horses (P < 0.0001) but returned to pre-SET levels by 1 h post-SET in horses receiving SCFP. At 6 h post-SET, cortisol concentrations in CON horses returned to pre-SET concentrations, whereas cortisol declined further in SCFP horses to below pre-SET levels (P = 0.0002) and lower than CON (P = 0.003) at that time point. SAA increased at 6 h post-SET in CON (P < 0.0001) but was unchanged through 6 h in SCFP horses. All cytokines except G-CSF increased in response to the SET (P < 0.0001) but showed differing response patterns. Concentrations of IL-1β, IL-6, and tumor necrosis factor-alpha were lesser (P ≤ 0.05), and concentrations of G-CSF and IL-18 tended to be lesser (P ≤ 0.09) in SCFP compared with CON horses throughout recovery from the SET. In summary, 8 wk of dietary supplementation with 21 g/d of SCFP may mitigate cellular stress following a single, prolonged submaximal exercise bout in young horses.     

Effect of dose of furosemide on plasma tCO2 changes in standardbred horses

Nine Standardbred horses of similar athletic fitness (six mares, three geldings), ranging from 4 to 11 years of age, were used to determine the effects of 0, 250, or 500 mg intravenously administered furosemide on plasma tCO₂ changes over time. All horses were either currently racing or in advanced stages of race training before entering a qualifying race. Horses were randomly allotted to one of the three treatment levels of furosemide during 3 consecutive weeks. Jugular venous samples were obtained from horses at rest in box stalls before and hourly for 6 hours after administration of furosemide. Body weights of horses ranged from 356 to 456 kg, and the mean was 417 kg. Thus, the dose of furosemide received by each horse ranged from 0.55 to 0.70 mg/kg body weight for the 250-mg injections and from 1.1 to 1.4 mg/kg body weight for the 500-mg injections. Furosemide caused metabolic alkalosis in the horses. Least square means (±SEM) were determined and horses had adjusted plasma tCO₂ of 32.2, 33.9, and 34.7 ± 0.41 for the 0-, 5-, and 10-mL doses of furosemide, respectively. The type 3 tests of hypotheses found that there was a difference (P < .0001) across time, a difference (P = .0016) according to furosemide dose, and a difference (P < .0001) according to treatment × hour. There was no difference (P > .05) according to week or treatment × week. These data suggest that either 250 or 500 mg furosemide given to Standardbred race horses induces statistically similar metabolic alkalosis.     

The Effectiveness of Immunotherapy in Treating Exercise-Induced Pulmonary Hemorrhage

Inflammatory airway disease has been linked to exercise-induced pulmonary hemorrhage (EIPH), and consequently, we hypothesized that immunomodulation via concentrated equine serum (CES) treatment would reduce EIPH as evidenced by red blood cell (RBC) concentrations in bronchoalveolar lavage fluid (BALF). Separate trials were conducted on Thoroughbred horses treated with either CES (n = 6) or placebo (0.9% saline; n = 4). All horses completed pre-treatment and post-treatment (2 and 4 weeks after initiating treatment) maximal exercise tests on a 10% inclined treadmill (1 m/s/min increments to fatigue) over a 10-week period (2−3 weeks between tests), with bronchoalveolar lavage (BAL) performed 30 minutes after exercise. Treatment ensued 10 days after the pre-treatment exercise test, with horses receiving a series of five CES or placebo injections 24 hours apart (20 mL intratracheal and 10 mL intravenously), with subsequent weekly injections for 5 weeks thereafter. After CES treatment, both EIPH (RBC in BALF) and inflammation (white blood cell concentration [WBC] in BALF) were significantly diminished by the 4-week posttreatment run, demonstrating 46 ± 12% and 24 ± 11% decreases, respectively (P < 0.05). In contrast, EIPH was elevated significantly at the 4-week time point, and inflammation remained constant in the placebo trial. In conclusion, these preliminary data suggest that therapeutic intervention involving immunomodulation may represent a viable approach to reducing the severity of EIPH.     

Effect of biotin supplementation on the vLa4 of thoroughbred horses

Thoroughbred horses in racing condition were supplemented twice daily with 25 mg biotin (biotin group), while control horses received an equivalent amount of maltodextrose as a placebo (placebo group). Changes of v_fLa4 (running speed necessary for producing a lactate concentration of 4 mmol/l in the blood) were determined with an incremental step test within three days and after two, three and four months after the beginning of supplementation. The mean v_fLa4 of both the biotin and the placebo groups (5 horses each) did not change significantly within three days of supplementation, but the mean plasma biotin concentration increased in the biotin group from 1.3±0.4 to 47±22 nmol/l (p<0.01), while remaining below 3 nmol/1 in the placebo group. There was no significantly different development of the v_fLa4 between groups over four months of supplementation. But, while the mean v_fLa4 of Thoroughbreds supplemented with biotin over this period of time did not show any changes, the v_fLa4 of the placebo group horses showed a tendency to decrease. In the biotin group, the mean plasma biotin levels varied between 38 and 64 nmol/l over the four months, while the biotin concentration of the placebo group never exceeded 3 nmol/1.     

Naproxen in the horse: Pharmacokinetics and side effects in the elderly

It is well-known that old animals show physiologic and/or pathologic variation that could modify the pharmacokinetics of drugs and the related pharmacodynamic response. In order to define the most appropriate therapeutic protocol in old horses, pharmacokinetic profile and safety of naproxen were investigated in horses aged over 18 years after oral administration for 5 days at the dose of 10 mg/kg b.w./day. After the first administration, the maximum concentration (C_max 44.21 ± 9.21 μg/mL) was reached at 2.5 ± 0.58 h post-treatment, the harmonic mean terminal half-life was 6.96 ± 1.73 h, AUC_0–24h was 459.71 ± 69.95 h μg/mL, MRT was 7.44 ± 0.74 h and protein binding was 98.47 ± 2.72%. No drug accumulation occurred with repeated administrations. No clinical and laboratory changes were detected after administration of naproxen. Gastric endoscopies performed after the treatment did not show pathological changes of the gastric mucosa.     

Effectiveness of maifanite in reducing the detrimental effects of aflatoxin B1 on hematology,aflatoxin B1 residues,and antioxidant enzymes activities of weanling piglets

A feeding trial was conducted to evaluate the effectiveness of maifanite, which is mainly composed of aluminosilicate, in reducing the adverse effects of aflatoxin B₁ (AFB₁) on hematology, AFB₁ residues, and antioxidant enzymes activities in weaning piglets. A total of 32 (9.28±0.17 kg BW) individually housed crossbred piglets (Duroc×Landrace×Large white) were randomly allotted to 1 of 4 dietary treatments in a 2×2 factorial arrangement with 8 replicates per treatment. The dietary treatments included 2 AFB₁ levels (5.3 and 372.8 μg/kg) and 2 maifanite levels (0% and 1%). No differences in average daily gain, average daily feed intake, and gain to feed ratio were observed among treatments. Ingestion of the AFB₁-contaminated (AF) diets (372.8 μg/kg of AFB₁) reduced (P<0.05) the numbers of neutrophil, monocyte, and total leukocyte. There were no effects of AFB₁ on gamma glutamyltransferase, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase activities, and total protein, albumin, urea N, total bilirubin, IgG, IgA, and IgM concentrations in serum. Aflatoxin B₁ was found in the liver and kidney of piglets fed the AF diets. Piglets fed the AF diets reduced (P<0.05) the total superoxide dismutase, glutathione peroxidase, and catalase activities in serum. However, total superoxide dismutase activity in the liver was increased (P<0.05) in piglets fed the AF diets compared with those fed the basal diets (5.3 μg/kg of AFB₁). There was an interaction (P=0.003) in erythrocyte, but piglets fed the diets containing maifanite had greater erythrocyte and lymphocyte (P=0.035) numbers than those fed the diets without maifanite. The AFB₁ levels in the liver and kidney of piglets fed the AF diet containing maifanite were 29.6% and 41.2% lower, respectively, than those of piglets fed the AF diet alone. Although there was an interaction (P=0.011), piglets fed the diets containing AFB₁ and maifanite had greater serum T-SOD activity compared with those fed the diets with no maifanite. In conclusion, the addition of maifanite to the AF diet resulted in partial restoration of hematology and antioxidant enzymes activities and reduced AFB₁ levels in the liver and kidney.     

Change in Some Physiologic Variables Induced by Italian Traditional Conditioning in Standardbred Yearling

The goal of this study was to quantify the effect of a traditional Italian conditioning method (CM). Six Standardbred yearlings were kept in standardized conditions for 140 days. From T1 (day 1) to T10 (day 10), the horses were hitched for 30 minutes/day to accustom them to a cart. From T11 to T70, they were jogged or exercised for 30 minutes/day at a slow trot (4.4 ± 0.3 m/second) and from T71 to T140 for 40 minutes/day (5 m/second ± 0.3 m/second). Every 15 days, the horses performed fast exercise for a distance of 5,000 m with increased speeds. Blood samples were collected before and after daily training (DT) every 21 days (P1…P7), to measure the following variables: erythrocytes (RBC), hemoglobin (Hb), packed cell volume (PCV), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV), total protein (Pt), albumin, aspartate amino transferase (AST), alkaline phosphatase (ALP), creatine kinase (CK), lactate dehydrogenase (LDH), urea, creatinine, glucose, triglycerides, and blood lactate. A three-step standardized exercise test (SET) also was performed. Analysis of variance was used to study differences during the training. Tukey's post-hoc test was used for statistical multiple comparison (P ≤ 0.05 and 0.01). Lactate level did not show an increase over 4 mmol/L in all periods. Glucose was higher at P1 than P7. There was no correlation between method of conditioning and the level of CK, LDH, or AST. Conditioning method induced an increase in triglycerides for the change in exercise metabolism supply. According to SET, conditioning method induced an increase of SVO2_max (speed [m/second] reached to a theoretical maximal oxygen consumption), V₄ (speed [m/second] reached at a lactate content of 4 mmol/L), V₂₀₀ (speed [m/second] at 200 beats/minute) and HR₄ (heart rate [beats/minute] at 4 mmol/L of lactate). We concluded that the Italian conditioning method used in this study improved the fitness of horses.     

Growth Hormone and Prolactin Secretion in Horses: Effects of Multiple and Extended Exercise Bouts, β-Hydroxy-β-Methyl Butyrate Feeding,and Arginine and Thyrotropin-Releasing Hormone Pretreatment

Five experiments were performed to test the overall hypothesis that exercise might be a useful indicator of growth hormone (GH) and prolactin status in horses. In experiment 1, geldings were exercised for 5 minutes four times at hourly intervals. The prolactin response (P < .05) to the first two exercise bouts was small and increased with successive bouts. There was a consistent GH response (P < .05) for only the first two bouts. In experiment 2, geldings were exercised for 29 to 39 minutes on a treadmill. After the initial bout, half the geldings were supplemented daily with Ca-β-hydroxy-β-methyl butyrate, and all geldings were conditioned for 12 weeks. Exercise bouts at 7 and 12 weeks indicated no effect (P > .1) of supplementation. In experiment 3, treatment of geldings with arginine before exercise increased (P < .001) prolactin concentrations but had no effect (P > .1) on the GH response to exercise. In experiment 4, the repeatability of the GH response to 5 minutes of exercise was determined by exercising eight stallions on six separate occasions. In addition to a large variation in GH response among stallions, there was a large variation within each stallion. In experiment 5, pretreatment with thyrotropin-releasing hormone 2 hours before exercise did not normalize the GH response to exercise. In conclusion, factors affecting the GH response to exercise likely preclude its usefulness as an indicator of GH status in horses.     

Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites

Epoxomicin potently and irreversibly inhibits the catalytic activity of proteasomal subunits. Treatment of proliferating cells with epoxomicin results in cell death through accumulation of ubiquinated proteins. Thus, epoxomicin has been proposed as a potential anti-cancer drug. In the present study, the inhibitory effects of epoxomicin on the in vitro growth of bovine and equine Babesia parasites were evaluated. The inhibitory effect of epoxomicin on the in vivo growth of Babesia microti was also assessed. The in vitro growth of five Babesia species that were tested was significantly inhibited (P < 0.05) by nanomolar concentrations of epoxomicin (IC₅₀ values = 21.4 ± 0.2, 4 ± 0.1, 39.5 ± 0.1, 9.7 ± 0.3, and 21.1 ± 0.1 nM for Babesia bovis, Babesia bigemina, Babesia ovata, Babesia caballi, and Babesia equi, respectively). Epoxomicin IC₅₀ values for Babesia parasites were low when compared with diminazene aceturate and tetracycline hydrochloride. Combinations of epoxomicin with diminazene aceturate synergistically potentiated its inhibitory effects in vitro on B. bovis, B. bigemina, and B. caballi. In B. microti-infected mice, epoxomicin caused significant (P < 0.05) inhibition of the growth of B. microti at the non-toxic doses of 0.05 and 0.5 mg/kg BW relative to control groups. Therefore, epoxomicin might be used for treatment of babesiosis.     

Effect of weaning age and postweaning feeding programme on the growth performance of pigs to 10 weeks of age

This study aimed to determine the effects of weaning age and postweaning feeding programme on pig performance and health. In experiment 1, 96 same gender pairs of pigs weaned at 3, 4 and 5 weeks of age were used in a 3 (weaning age)×4 (dietary programme) factorial design experiment. Pigs received different amounts of a phase 1 diet (16.2 MJ/kg digestible energy (DE) and 16.2 g/kg lysine) and phase 2 diet (15.3 MJ/kg DE and 15.0 g/kg lysine): (A) very low (VL, 1 kg phase 1 and 3 kg phase 2 diet per pig); (B) low (L, 2 kg phase 1 and 6 kg phase 2 diet per pig); (C) medium (M, 3 kg phase 1 and 9 kg phase 2 diet per pig) or (D) high (H, 4 kg phase 1 and 12 kg phase 2 diet per pig), followed by a cereal based phase 3 diet (15.0 MJ/kg DE and 13.8 g/kg lysine) to 10 weeks of age. In experiment 2, faecal samples from 60 pigs weaned at 3, 4 and 5 weeks of age were collected at 10 days postweaning and analysed for Escherichia coli and lactic acid bacteria counts. In experiment 1, there were no interaction effects of age×dietary programme on growth performance. Dietary programme did not affect growth performance from weaning to 10 weeks of age. From weaning to 10 weeks of age, increasing weaning age increased average daily gain (ADG; 363, 402, and 476 g for 3, 4 and 5 weeks respectively; s.e. 17.6; P<0.001), average daily feed intake (ADFI; 560, 620, and 680 g; s.e. 26.1; P<0.001), and improved feed conversion ratio (FCR; 1.57, 1.55, and 1.43; s.e. 0.045; P<0.05). However, weaning age had no effect (P>0.05) on pig weight at 10 weeks of age. In experiment 2, 3 week weaned pigs had higher faecal counts of E. coli (P<0.05) than 4 week weaned pigs and higher faecal counts of lactic acid bacteria (P>0.01) than 5 week weaned pigs at 10 days postweaning. In conclusion, feeding higher amounts of phases 1 and 2 diets did not affect performance at any of the weaning ages tested. Increasing weaning age increased growth performance between weaning and 10 weeks of age, but had no effect on the resulting body weight. Pigs weaned at 3 weeks of age had increased counts of selected faecal bacteria compared to those weaned later.     

Disposition of marbofloxacin in vulture (Gyps fulvus) after intravenous administration of a single dose

The pharmacokinetics properties of marbofloxacin were studied in adult Eurassian Griffon vulture after single-dose intravenous (IV) administration of 2 mg/kg. Drug concentration in plasma was determined by high-performance liquid chromatography and the data obtained were subjected to compartmental and non-compartmental kinetic analysis. Marbofloxacin presented a volume of distribution at steady-state (Vdss) of 1.51 ± 0.22 L and total plasma clearance (Cl) of 0.109 ± 0.023 L/h kg. The permanence of this drug was long in vultures (T_1/2λ = 12.51 ± 2.52 h; MRT_∞ = 13.54 ± 2.29 h). The optimal dose of marbofloxacin estimated is 2.73 mg/kg per day for the treatment of infections in vultures with MIC₉₀ = 0.2 μg/mL.     

Effect of gentle stroking and vocalization on behaviour,mucosal immunity and upper respiratory disease in anxious shelter cats

Emotional, behavioural, and health benefits of gentle stroking and vocalizations, otherwise known as gentling, have been documented for several species, but little is known about the effect of gentling on cats in stressful situations. In this study, 139 cats rated as anxious upon admission to an animal shelter were allocated to either a Gentled or Control group. Cats were gentled four times daily for 10 min over a period of 10 days, with the aid of a tool for cats that were too aggressive to handle. The cats’ mood, or persistent emotional state, was rated daily for 10 d as Anxious, Frustrated or Content. Gentled cats were less likely to have negatively valenced moods (Anxious or Frustrated) than Control cats (Incidence Rate Ratio [IRR] = 0.61 CI 0.42–0.88, P = 0.007). Total secretory immunoglobulin A (S-IgA) was quantified from faeces by enzyme-linked immunosorbent assay. Gentled cats had increased S-IgA (6.9 ± 0.7 log_e μg/g) compared to Control cats (5.9 ± 0.5 log_e μg/g) (P < 0.0001). Within the Gentled group of cats, S-IgA values were higher for cats that responded positively to gentling (7.03 ± 0.6, log_e μg/g), compared with those that responded negatively (6.14 ± 0.8, log_e μg/g). Combined conjunctival and oropharyngeal swab specimens were tested by quantitative real-time polymerase chain reaction (rPCR) for feline herpesvirus type 1 (FHV-1), feline calicivirus (FCV), Mycoplasma felis, Chlamydophila felis, and Bordetella bronchiseptica. There was a significant increase in shedding over time in Control cats (23%, 35%, 52% on days 1, 4 and 10, respectively), but not in gentled cats (32%, 26%, 30% on days 1, 4 and 10, respectively) (P = 0.001). Onset of upper respiratory disease was determined by veterinary staff based on clinical signs, in particular ocular and/or nasal discharge. Control cats were 2.4 (CI: 1.35–4.15) times more likely to develop upper respiratory disease over time than gentled cats (P < 0.0001). It is concluded that gentling anxious cats in animal shelters can induce positive affect (contentment), increase production of S-IgA, and reduce the incidence of upper respiratory disease.     

Effects of 1,25-dihydroxyvitamin D3 on calcium and phosphorus homeostasis in sheep fed diets either adequate or restricted in calcium content

It was the aim of the present study to collect basic data on calcium (Ca) and phosphorus (P) homoeostasis in sheep. Two series of experiments were carried out to investigate the effects of 1,25-dihydroxyvitammin D₃ (calcitriol) in supraphysiological dosage in combination with varying alimentary Ca supply. In the first series, blood samples were collected over 72 h to determine the concentrations of total Ca (Ca), ionized Ca (Ca²⁺), inorganic phosphate (P_i), and the bone resorption marker CrossLaps (CL). In the second series, measurements were carried out over 12 h. In addition, urine samples were collected to calculate the fractional excretions (FE) of Ca and P_i. Changes in plasma macromineral concentrations (P < 0.01) as well as in CL (P < 0.001) and endogenous calcitriol (P < 0.05) were observed in the alimentary Ca-restricted animals, indicating that the reduction of daily Ca intake challenged the animals’ macromineral homeostatic mechanisms. However, the Ca-restricted diet had an effect on neither FE of Ca nor on FE of P_i. The treatment resulted in peak serum calcitriol concentrations between 1,900 and 2,500 pg/mL, and supraphysiological concentrations were maintained for the next 48 h. Irrespective of dietary Ca, calcitriol had hypercalcemic and hyperphosphatemic effects. An increase in CL was revealed only in the Ca-restricted, calcitriol-treated sheep (P < 0.01), reflecting a remarkable enhancement of Ca mobilization from the bone by calcitriol exclusively in this group. From these data, it can be concluded that the sheep can be a suitable animal model for studying catabolic effects of Ca deficiency and calcitriol on bone metabolism.     

Purification of cattle oviduct specific proteins and their effect on in vitro embryo development

The purpose of this study was to determine the effect of oviduct specific proteins as a media supplement for in vitro embryo development in cattle. The proteins were extracted from oviducts of cows and precipitated by ammonium sulfate (30%, 40%, 50% and 60%) followed by dialysis in 50 mM Tris–HCl (pH 7.0) buffer. The dialyzed proteins were fractionated into acidic, basic and neutral fractions using SP sephadex cation exchange and DEAE sephadex anion exchange column chromatography respectively. Cow oviduct specific proteins (cOSPs) constituting all the extracted proteins were used as media supplement in three different concentrations (10, 50 and 100 μg/ml) for in vitro maturation, fertilization and culture (IVMFC) of cow oocytes. Acidic, basic and neutral (unbound) fractions were also used as media supplement in three different concentrations (10, 30 and 50 μg/ml) for IVMFC. Cumulus oocytes complexes were collected from slaughterhouse ovaries, washed thoroughly and cultured in maturation media for 24 h in 5% CO₂ at 38.5 °C with maximum humidity. In vitro matured oocytes were co-incubated with in vitro capacitated sperm in Fert-BO media at 38.5 °C for 18 h in 5% CO₂. The fertilized oocytes were washed and cultured in embryo development media for cleavage. After 40–42 h cleavage was observed and embryos were put in the replacement media for further development. The cleavage rates (%) for cOSPs were observed as 68.24±2.46, 69.28±2.05, 61.77±0.93 and 42.62±1.31 at concentrations of 0, 10, 50 and 100 μg/ml respectively. Rates of blastocyst stage development were 14.49±3.61, 21.17±2.77, 14.66±1.06 and 11.98±1.84. These results indicate that addition of cOSP at10 μg/ml increased blastocyst formation as compared to other concentrations (0, 50 and 100 μg/ml). Although acidic, basic and neutral fractions seemed to have no major effect on cleavage rate, but both acidic and neutral fraction of oviduct specific proteins improved the cleavage rate at 30 μg/ml concentration and basic fraction improved the blastocyst formation at 10 μg/ml concentration.     

Pharmacokinetics and bioavailability of a long-acting formulation of cephalexin after intramuscular administration to cats

The pharmacokinetic profile and bioavailability of a long-acting formulation of cephalexin after intramuscular administration to cats was investigated. Single intravenous (cephalexin lysine salt) and intramuscular (20% cephalexin monohydrate suspension) were administered to five cats at a dose rate of 10 mg/kg. Serum disposition curves were analyzed by noncompartmental approaches. After intravenous administration, volume of distribution (V_z), total body clearance (Cl_t), elimination constant (λ_z), elimination half-life (t_½λ) and mean residence time (MRT) were: 0.33 ± 0.03 L/kg; 0.14 ± 0.02 L/h kg, 0.42 ± 0.05 h⁻¹, 1.68 ± 0.20 h and 2.11 ± 0.25 h, respectively. Peak serum concentration (C_max), time to peak serum concentration (T_max) and bioavailability after intramuscular administration were 15.67 ± 1.95 μg/mL, 2.00 ± 0.61 h and 83.33 ± 8.74%, respectively.     

Effect of Ergopeptines Associated with Tall Fescue Ingestion on Recovery of Horses Subjected to Standardized Exercise Tests

Ten horses were paired by body weight, age, and skill level, and one of each pair was assigned to one of two groups. Horses were fed alfalfa hay and a mixture of commercial sweet feed and pellets. Horses in group A were fed fescue seed that contained both ergovaline and ergotamine (E+), whereas those in the other group were fed seed that was free from ergot alkaloids (E−). After the first 35 days, horses were switched to the opposite seed treatment. Seed was fed at 8.2% of the diet, resulting in 406 ppb of ergotamine plus ergovaline in the E+ diet. During weeks 3, 5, 7, and 10, horses were subjected to two separate standardized exercise tests (SETs). The aerobic test consisted of walking, trotting, and loping and was designed to maintain horse's heart rate (HR) to less than 150 beats per minute (bpm). The anaerobic test consisted of 40 turns in less than 4 minutes in response to the movements of a mechanical cow and was designed to increase the horse's HR to more than 150 bpm. There were no treatment effects on water consumption or sweat production. There were also no treatment effects on rectal temperature at rest or during recovery from the anaerobic SET. However, rectal temperatures were higher (P < .05) 1 and 30 minutes after the aerobic SET for horses consuming E+ seed. When horses were on the E+ treatment, HRs were lower (P < .05), both at rest and during the SET. HRs were also lower (P < .05) for the E+ treatment at 1 minute after the aerobic test and 5 and 10 minutes after the anaerobic test. Respiration rates were higher (P < .05) 30 minutes after the aerobic SET and 30 and 60 minutes after the anaerobic SET for the E+ treatment. Horses may have increased respiration rates to compensate for a reduction in the efficiency of evaporative cooling, which resulted from vasoconstriction of peripheral blood vessels.